MARKET

OSUR

OSUR

OraSure Tech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.02
-0.25
-2.70%
Closed 19:06 05/05 EDT
OPEN
9.29
PREV CLOSE
9.27
HIGH
9.41
LOW
8.95
VOLUME
797.79K
TURNOVER
--
52 WEEK HIGH
19.75
52 WEEK LOW
8.95
MARKET CAP
655.27M
P/E (TTM)
-37.5520
1D
5D
1M
3M
1Y
5Y
OraSure Technologies Stock Is Estimated To Be Modestly Undervalued
GuruFocus News · 5h ago
8-K: ORASURE TECHNOLOGIES INC
(EDGAR Online via COMTEX) -- false 0001116463 0001116463 2021-05-05 2021-05-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 13h ago
OraSure Technologies (OSUR) Beats Q1 Earnings and Revenue Estimates
Zacks.com · 14h ago
OraSure Technologies EPS beats by $0.01, beats on revenue
OraSure Technologies (OSUR): Q1 GAAP EPS of $0.05 beats by $0.01.Revenue of $58.58M (+85.4% Y/Y) beats by $1.58M.Shares +3.99%.Press Release
Seekingalpha · 15h ago
BRIEF-Orasure Technologies Announces Q1 2021 Financial Results And Provides Covid-19 Update
reuters.com · 15h ago
OraSure Technologies Q1 EPS $0.05 Beats $0.04 Estimate, Sales $59.00M Beat $57.00M Estimate
OraSure Technologies (NASDAQ:OSUR) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.04 by 25 percent. This is a 150 percent increase over losses of $(0.10) per share from the
Benzinga · 15h ago
OraSure Technologies, Inc. Announces First Quarter 2021 Financial Results and Provides COVID-19 Update
First Quarter 2021 Net Revenues of $59 Million Increased 85% Over 2020, Driven by $27 Million in Sales of Sample Collection Devices for COVID-19 Molecular Testing
GlobeNewswire · 15h ago
OraSure Technologies, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 5, 2021 / OraSure Technologies, Inc. (NASDAQ:OSUR) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 5:00 PM Eastern Time.
ACCESSWIRE · 16h ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of OSUR. Analyze the recent business situations of OraSure Tech through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average OSUR stock price target is 17.00 with a high estimate of 24.00 and a low estimate of 12.00.
EPS
Institutional Holdings
Institutions: 308
Institutional Holdings: 74.76M
% Owned: 102.91%
Shares Outstanding: 72.65M
TypeInstitutionsShares
Increased
64
7.62M
New
33
1.87M
Decreased
61
6.38M
Sold Out
27
4.71M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.94%
Healthcare Equipment & Supplies
-0.58%
Key Executives
Non-Executive Chairman/Independent Director
Michael Celano
President/Chief Executive Officer/Director
Stephen Tang
Chief Financial Officer
Roberto Cuca
Executive Vice President
Lisa Nibauer
Executive Vice President
Kathleen Weber
Senior Vice President/Chief Compliance Officer/General Counsel/Secretary
Jack Jerrett
Vice President - Finance/Controller
Michele Miller
Independent Director
Mara Aspinall
Independent Director
James Datin
Independent Director
Eamonn Hobbs
Independent Director
Ronny Lancaster
Independent Director
Lelio Marmora
Independent Director
David Shulkin
No Data
  • All
  • Financials
  • Insiders
More
About OSUR
OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing.

Webull offers kinds of OraSure Technologies, Inc. stock information, including NASDAQ:OSUR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OSUR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OSUR stock methods without spending real money on the virtual paper trading platform.